Original document(36 pages) Authorized document(37 pages) 中文版
    A urinary incontinence treatment apparatus comprises a restriction device (56) implantable in a patient, for engaging the urethra or urine bladder to form a restricted urine passageway in the urethra or urine bladder. The restriction device is operable by an implantable operation device (60) to change the restriction of the urine passageway. A control device (62 and 64) is provided for controlling a source of energy, which may or may not be implanted, from outside the patient's body, to release energy for use in connection with the operation of the restriction device, i.e. to power the operation device.
Application Number
申请号
01804878 Application Date
申请日
2001.02.08
Title 名称 Controlled urinary incontinence treatment
Publication Number
公开号
1404377 Publication Date
公开日
2003.03.19
Approval Pub. Date 2005.05.25 Granted Pub. Date 2005.05.25
International Classification 分类号 A61F2/48;A61F5/48
Applicant(s) Name
申请人
Potensiya Medical AG
Address 地址
Inventor(s) Name 发明人 P. Forsell
Attorney & Agent 代理人 wu limeng liang yong

  
Patch with a fast-opening package, and method of and device for manufacturing the package
Method for cosmetic operation
Foot massage apparatus
Plastic container for liquid medicine
Squalane containing ultra fine particles of burning residue of carbon and method for producing the same
Cosmetic composition comprising a dispersion of polymer particles and a dispersion of pigments
Novel primary intermediate for use in oxidative hair dyeing
Method of using a beverage composition for treating dental erosion
Compositions containing heteropolymers and oil-soluble polymers and methods of using same
Cosmetic preparations containing plant extracts
Google
Note:All patent data come from State Intellectual Property Office of the People's Republic of China. If there were discrepancies between here and the State Intellectual Property office, the later is more accurate. The patent data is only for public exchange and learning purposes. We are not responsible for the adverse consequences with unverified use of the data.